Table 4.
Risk of ESKD among PH patients with and without NC.
| Group of PH patients | Hazard ratio (95% CI) |
||
|---|---|---|---|
| Total NC | Prevalent NC | Incident NCb | |
| All PH types (N=235, 57 ESKD) | |||
| No adjustment | 2.1 (1.2–3.6) | 1.5(0.8–2.8) | 5.1(2.4–11.0) |
| Adjusting PH1, patients by family screening and age on 1st image | 1.7 (1.0–3.0) | 1.2 (0.6–2.3) | 4.0 (1.9–8.5) |
| Adjusting PH1 and stone numbers on 1st imagea | 3.9 (1.7–8.9) | 1.6 (0.4–5.7) | 8.2 (3.2–21.3) |
| PH1 subgroup (N=170, 56 ESKD) | |||
| No adjustment | 1.5 (0.9–2.5) | 1.1 (0.6–2.0) | 3.6(1.7–7.7) |
| Adjusting patients by family screening and age on 1st image | 1.6 (0.9–2.9) | 1.2 (0.6–2.3) | 3.6 (1.6–7.8) |
| Adjusting stone numbers on 1st imagea | 3.5 (1.5–8.3) | 1.6 (0.4–5.7) | 6.9 (2.6–19.0) |
Patients who had ESKD before first image were excluded in the analysis.
a
Stone number is available for 140 PH patients with 25 ESKD events overall, and for 94 PH1 patients with 24 ESKD events.
b
patients with prevalent NC are those who found NC on first image. Patients with incident NC are those who had new NC during follow-up.